248 related articles for article (PubMed ID: 38645331)
1. New Salicylanilide Derivatives and Their Peptide Conjugates as Anticancer Compounds: Synthesis, Characterization, and
Horváth L; Biri-Kovács B; Baranyai Z; Stipsicz B; Méhes E; Jezsó B; Krátký M; Vinšová J; Bősze S
ACS Omega; 2024 Apr; 9(15):16927-16948. PubMed ID: 38645331
[TBL] [Abstract][Full Text] [Related]
2. In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.
Baranyai Z; Krátký M; Vosátka R; Szabó E; Senoner Z; Dávid S; Stolaříková J; Vinšová J; Bősze S
Eur J Med Chem; 2017 Jun; 133():152-173. PubMed ID: 28384546
[TBL] [Abstract][Full Text] [Related]
3. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
4. Host cell targeting of novel antimycobacterial 4-aminosalicylic acid derivatives with tuftsin carrier peptides.
Borbála Horváth L; Krátký M; Pflégr V; Méhes E; Gyulai G; Kohut G; Babiczky Á; Biri-Kovács B; Baranyai Z; Vinšová J; Bősze S
Eur J Pharm Biopharm; 2022 May; 174():111-130. PubMed ID: 35378278
[TBL] [Abstract][Full Text] [Related]
5. Cellular Internalization and Inhibition Capacity of New Anti-Glioma Peptide Conjugates: Physicochemical Characterization and Evaluation on Various Monolayer- and 3D-Spheroid-Based
Baranyai Z; Biri-Kovács B; Krátký M; Szeder B; Debreczeni ML; Budai J; Kovács B; Horváth L; Pári E; Németh Z; Cervenak L; Zsila F; Méhes E; Kiss É; Vinšová J; Bősze S
J Med Chem; 2021 Mar; 64(6):2982-3005. PubMed ID: 33719423
[TBL] [Abstract][Full Text] [Related]
6. Salicylanilide ester prodrugs as potential antimicrobial agents--a review.
Krátký M; Vinsová J
Curr Pharm Des; 2011; 17(32):3494-505. PubMed ID: 22074422
[TBL] [Abstract][Full Text] [Related]
7. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the metabolism and elimination of benzanilide and salicylanilide in the rat.
Mitchell SC; Norbury HM; Waring RH; Gadsden PM; Wood PB
Xenobiotica; 1982 Feb; 12(2):93-9. PubMed ID: 7090426
[TBL] [Abstract][Full Text] [Related]
9. Antistaphylococcal activity of novel salicylanilide derivatives.
Mollaghan A; Vinsova J; Imramovsky A; Cotter L; Lucey B; O'Mahony J; Costelloe A; Coffey A
Curr Drug Discov Technol; 2012 Mar; 9(1):39-47. PubMed ID: 21644919
[TBL] [Abstract][Full Text] [Related]
10. A Novel Salicylanilide Derivative Induces Autophagy Cell Death in Castration-Resistant Prostate Cancer via ER Stress-Activated PERK Signaling Pathway.
Hsieh CL; Huang HS; Chen KC; Saka T; Chiang CY; Chung LWK; Sung SY
Mol Cancer Ther; 2020 Jan; 19(1):101-111. PubMed ID: 31530650
[TBL] [Abstract][Full Text] [Related]
11. Salicylanilides and Their Anticancer Properties.
Kauerová T; Pérez-Pérez MJ; Kollar P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675241
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
Krátký M; Volková M; Novotná E; Trejtnar F; Stolaříková J; Vinšová J
Bioorg Med Chem; 2014 Aug; 22(15):4073-82. PubMed ID: 24953953
[TBL] [Abstract][Full Text] [Related]
13. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of p-O-Alkyl Salicylanilide Derivatives as Novel EGFR Inhibitors.
Zhang L; Hou L; Sun W; Yu Z; Wang J; Gao H; Yang G
Drug Dev Res; 2016 Feb; 77(1):37-42. PubMed ID: 26763193
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
16. A monofunctional platinum(II)-based anticancer agent from a salicylanilide derivative: Synthesis, antiproliferative activity, and transcription inhibition.
Wang B; Wang Z; Ai F; Tang WK; Zhu G
J Inorg Biochem; 2015 Jan; 142():118-25. PubMed ID: 25450026
[TBL] [Abstract][Full Text] [Related]
17. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
Krátký M; Vinšová J; Novotná E; Stolaříková J
Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of salicylanilides as novel allosteric inhibitors of human pancreatic lipase.
Zhao Y; Zhang M; Hou X; Han J; Qin X; Yang Y; Song Y; Liu Z; Zhang Y; Xu Z; Jia Q; Li Y; Chen K; Li B; Zhu W; Ge G
Bioorg Med Chem; 2023 Aug; 91():117413. PubMed ID: 37490786
[TBL] [Abstract][Full Text] [Related]
19. Photoaffinity labeling of benzophenone-containing salicylanilide compounds to give an insight into the mechanism in disrupting peptidoglycan formation.
Chuang HC; Liu MF; Wu HY; Wu YT; Cheng TR; Fang JM
Bioorg Med Chem; 2022 Aug; 67():116819. PubMed ID: 35635930
[TBL] [Abstract][Full Text] [Related]
20. Antifungal Activity of Salicylanilides and Their Esters with 4-(Trifluoromethyl)benzoic Acid.
Krátký M; Vinšová J
Molecules; 2012 Aug; 17(8):9426-42. PubMed ID: 22871645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
